[Clinicopathological study of salivary duct carcinoma]

Nihon Jibiinkoka Gakkai Kaiho. 2002 Jun;105(6):727-31. doi: 10.3950/jibiinkoka.105.727.
[Article in Japanese]

Abstract

Salivary duct carcinoma (SDC) was first described by Kleinsesser in 1968 and was classified as an independent entity by the 1991 Revised World Health Organization. It is a rare but highly malignant tumor. We reviewed pathology in 49 cases of salivary adenocarcinoma, and diagnosed 6 cases as SDC. All had a rapidly enlarged mass in the parotid gland. All were men, and 4 involved facial palsy and metastasis to cervical lymph nodes. Fine needle aspiration biopsy was conducted in 3 cases, but none was diagnosed as SDC. Two had chemotherapy, but showed no effect. All underwent surgery, but only 1 survived more than 4 years. Immunohistochemically, none showed s-100 protein. Four showed PCNA and p53 protein. Highly positive cells of PCNA and p53 were found around comedo necrosis.

Publication types

  • English Abstract

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / pathology*
  • Adenocarcinoma / surgery
  • Aged
  • Biomarkers, Tumor / analysis
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Prognathism
  • Proliferating Cell Nuclear Antigen / analysis
  • Salivary Ducts / pathology
  • Salivary Gland Neoplasms / diagnosis
  • Salivary Gland Neoplasms / pathology*
  • Salivary Gland Neoplasms / surgery
  • Tumor Suppressor Protein p53 / analysis

Substances

  • Biomarkers, Tumor
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53